Meta-analysis of serum copper and heart failure
2017-01-16 03:42AnqiZHANGLilaZHUXiyueZHANG
中國藥理學與毒理學雜志 2017年10期
An-qi ZHANG,Li-la ZHU,Xi-yue ZHANG
(Affiliated Clinical Medicine Department of Tianjin Medical University,Tianjin 300070,China）
T3-20
Meta-analysis of serum copper and heart failure
An-qi ZHANG,Li-la ZHU,Xi-yue ZHANG
(Affiliated Clinical Medicine Department of Tianjin Medical University,Tianjin 300070,China）
OBJECTIVEThe purpose of this study is to clarify the association between Cu levels and heart failure（HF）using a meta-analysis approach.METHODSWe searched articles in the PubMed,EMbase,CNKI,Wanfang,VIP and CBM Database published as of August 2016.The case control study on the relationship between serum copper levels and HF were collected and read and extracted by two independent researchers.A Meta analysis was conducted using Stata 12.0 software.RESULTSA total of twenty-one eligible articles,including 893 HF and 654 control subjects,were enrolled.The Meta analysis showed that serum copper levels in HF were higher than control group〔SMD=0.881,95%CI:(0.487,1.264),Z=4.5,P＜0.001〕.The sensitivity analysis indicated that the results were reliable.Begg′s tests did not find the existence of publication bias.CONCLUSIONThis metaanalysis indicates that there is a significant association between high Cu serum level and HF.
heart failure;serum cu;meta analysis
An-qi ZHANG,Tel:13920066582,E-mail：zanljf@163.com
- 中國藥理學與毒理學雜志的其它文章
- Pharmacological study on traditional Chinese medicine and natural product in China
- GPCRomics:tissue and cellular GPCR expression identifies new therapeutic targets
- Direction of new drug research:soft regulation of inflammatory immune responses
- Targeting Gprotein-coupled receptors for the treatment of autoimmune diseases
- Arrestin mediated GPCR biased signaling and its application in new drug discovery
- Identification of a novel target for cancer and anti-fibrotic therapy